Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Behavioral and Brain Functions
Published in: Behavioral and Brain Functions 1/2015

Open Access 01-12-2015 | Research

The protective effect of caffeic acid on global cerebral ischemia-reperfusion injury in rats

Authors: Guojuan Liang, Bin Shi, Weinan Luo, Junqing Yang

Published in: Behavioral and Brain Functions | Issue 1/2015

Login to get access

Abstract

Ischemic stroke is a major cause of death and disability all over the world. Ischemic stroke results from a temporary or permanent reduction of cerebral blood flow that leads to functional and structural damage in different brain regions. Despite decades of intense research, the beneficial treatment of stroke remains limited. In light of this, the search for effective means ameliorating cerebral ischemia-reperfusion injury (CIRI) is one of the major problems of experimental medicine and biology. Recently, the 5-Lipoxygenase (5-LO, a key enzyme metabolizing arachidonic acid to produce leukotrienes) inhibitors have been showed to protect brain against ischemic damage in animal model of cerebral ischemia. Caffeic acid, an inhibitor of 5-LO, is a phenolic compound widely distributed in medicinal plants. The aim of this study was to investigate the effect of caffeic acid on global cerebral ischemia-reperfusion injury in rats. The study was carried out on 45 rats that were randomly divided into five groups: the sham group (n = 9), I/R non-treated group (n = 9), I/R-caffeic acid group (10 mg · kg−1) (n = 9), I/R-caffeic acid group (30 mg · kg−1) (n = 9) and I/R-caffeic acid group (50 mg · kg−1) (n = 9). Global cerebral ischemia was induced by bilateral carotid artery occlusion for 20 min followed by reperfusion. Spatial learning and memory was evaluated using Morris water maze. Histopathological changes of hippocampus neurons was observed using HE staining. Superoxide dismutase (SOD, the antioxidant enzyme) activities and malondialdehyde (MDA, an oxidative stress biomarker) contents were detected. NF-κBp65 expression was detected by the methods of immunohistochemistry. Caffeic acid markedly reduced the escape latency, relieved hippocampal neurons injury and increased neuron count compared with those of I/R non-treated rat. NF-κBp65 expression and MDA content decreased significantly, and SOD activities increased significantly in hippocampus. Compared with sham group, 5-LO expression increase significantly in I/R non-treated group rat, and caffeic acid markedly reduced 5-LO expression. The results of the study suggest that caffeic acid has a significant protective effect on global cerebral ischemia-reperfusion injury in rats. The neuroprotective effects is likely to be mediated through the inhibition of 5-LO.
Literature
1.
Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Heart disease and stroke statistics-2010 up date: a report from the American heart association. Circulation. 2010;121(7):e46–e215.CrossRefPubMed
2.
3.
Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci. 2003;4(5):399–414.CrossRefPubMed
4.
Xiang J, Tang YP, Wu P, Gao JP, Cai DF. Chinese medicine Nao-Shuan-Tong attenuates cerebral ischemic injury by inhibiting apoptosis in a rat model of stroke. J Ethnopharmacol. 2010;131(1):174–81.CrossRefPubMed
5.
Yanpallewar SU, Hota D, Rai S, Kumar M, Acharya SB. Nimodipine attenuates biochemical, behavioral and histopathological alterations induced by acute transient and long-term bilateral common carotid occlusion in rats. Pharmacol Res. 2004;49(2):143–50.CrossRefPubMed
6.
McCord JM. Oxygen-derived free radicals in postischemic tissue injury. New Engl J Med. 1985;312(3):159–63.CrossRefPubMed
7.
Ozen OA, Cosar M, Sahin O, Fidan H, Eser O, Mollaoglu H, et al. The protective effect of fish n-3 fatty acids on cerebral ischemia in rat prefrontal cortex. Neurol Sci. 2008;29:147–52.CrossRefPubMed
8.
Shcherbak NS, Galagudza MM, Kuzmenkov AN, Ovchinnikov DA, Mitrofanova LB, Barantsevich ER, et al. A new rat model of reversible global cerebral ischemia. Bull Exp Biol Med. 2012;152(5):656–8.CrossRefPubMed
9.
Samuelsson B, Dahlén SE, Lindgren JA, Rouzer CA, Serhan CN. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science. 1987;237(4819):1171–6.CrossRefPubMed
10.
Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001;294(5548):1871–5.CrossRefPubMed
11.
Tomimoto H, Shibata M, Ihara M, Akiguchi I, Ohtani R, Budka H. A comparative study on the expression of cyclooxygenase and 5-lipoxygenase during cerebral ischemia in humans. Acta Neuropathol. 2002;104(6):601–7.PubMed
12.
Zhou Y, Fang SH, Ye YL, Chu LS, Zhang WP, Wang ML, et al. Caffeic acid ameliorates early and delayed brain injuries after focal cerebral ischemia in rats. Acta Pharmacol Sin. 2006;27(9):1103–10.CrossRefPubMed
13.
Zhang RL, Lu CZ, Ren HM, Xiao BG. Metabolic changes of arachidonic acid after cerebral ischemia-reperfusion in diabetic rats. Exp Neurol. 2003;184(2):746–52.CrossRefPubMed
14.
Ohtsuki T, Matsumoto M, Hayashi Y, Yamamoto K, Kitagawa K, Ogawa S, et al. Reperfusion induces 5-lipoxygenase translocation and leukotriene C4 production in ischemic brain. Am J Physiol. 1995;268(3 Pt 2):H1249–57.PubMed
15.
Ciceri P, Rabuffetti M, Monopoli A, Nicosia S. Production of leukotrienes in a model of focal cerebral ischaemia in the rat. Br J Pharmacol. 2001;133(8):1323–9.CrossRefPubMedCentralPubMed
16.
Shishido Y, Furushiro M, Hashimoto S, Yokokura T. Effect of nordihydroguaiaretic acid on behavioral impairment and neuronal cell death after forebrain ischemia. Pharmacol Biochem Behav. 2001;69(3–4):469–74.CrossRefPubMed
17.
Helgadottir A, Manolescu A, Thorleifsson G, Gretarsdottir S, Jonsdottir H, Thorsteinsdottir U, et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet. 2004;36(3):233–9.CrossRefPubMed
18.
Helgadottir A, Gretarsdottir S, St Clair D, Manolescu A, Cheung J, Thorleifsson G, et al. Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am J Hum Genet. 2005;76(3):505–9.CrossRefPubMedCentralPubMed
19.
Lõhmussaar E, Gschwendtner A, Mueller JC, Org T, Wichmann E, Hamann G, et al. ALOX5AP gene and the PDE4D gene in a central European population of stroke patients. Stroke. 2005;36(4):731–6.CrossRefPubMed
20.
Shi SS, Yang WZ, Tu XK, Wang CH, Chen CM, Chen Y. 5-Lipoxygenase inhibitor zileuton inhibits neuronal apoptosis following focal cerebral ischemia. J Neurophysiol. 2013;36(6):1209–17.
21.
Jatana M, Giri S, Ansari MA, Elango C, Singh AK, Singh I, et al. Inhibition of NF-kappaB activation by 5- lipoxygenase inhibitors protects brain against injury in a rat model of focal cerebral ischemia. J Neuroinflamm. 2006;3:12.CrossRef
22.
Tu XK, Yang WZ, Wang CH, Shi SS, Zhang YL, Chen CM, et al. Zileuton reduces inflammatory reaction and brain damage following permanent cerebral ischemia in rats. Inflammation. 2010;33:344–52.CrossRefPubMed
23.
Liu Y, Wang H, Zhu YM, Chen L, Qu YY, Zhu YL. The protective effect of nordihydroguaiaretic acid on cerebral ischemia/reperfusion injury is mediated by the JNK pathway. Brain Res. 2012;1445:73–81.CrossRefPubMed
24.
Sondheimer E. On the distribution of caffeic acid and the chlorogenic acid isomers in plants. Arch Biochem Biophys. 1958;74:131–8.CrossRefPubMed
25.
Nardini M, Pisu P, Gentili V, Natella F, Di Felice M, Piccolella E, et al. Effect of caffeic acid on tert-butyl hydroperoxide-induced oxidative stress in U937. Free Radic Biol Med. 1998;25:1098–105.CrossRefPubMed
26.
Miles EA, Zoubouli P, Calder PC, Phil D. Differential anti-inflammatory effects of phenolic compounds from extra virgin olive identified in human whole blood cultures. Nutrition. 2005;21:389–94.CrossRefPubMed
27.
Koshihara Y, Neichi T, Murota S, Lao A, Fujimoto Y, Tatsuno T. Caffeic acid is a selective inhibitor for leukotriene biosynthesis. Biochim Biophys Acta. 1984;792(1):92–7.CrossRefPubMed
28.
Koshihara Y, Neichi T, Murota S, Lao A, Fujimoto Y, Tatsuno T. Selective inhibition of 5-lipoxygenase by natural compounds isolated from Chinese plants, Artemisia rubripes Nakai. FEBS Lett. 1983;158(1):41–4.CrossRefPubMed
29.
Maurya DK, Devasagayam TP. Antioxidant and prooxidant nature of hydroxycinnamic acid derivatives ferulic and caffeic acids. Food Chem Toxicol. 2010;48(12):3369–73.CrossRefPubMed
30.
31.
Sánchez-Alonso I, Careche M, Moreno P, González MJ, Medina I. Testing caffeic acid as a natural antioxidant in functional fish-fibre restructured products. LWT-Food Sci Technol. 2011;44(4):1149–55.CrossRef
32.
Zhao ZH, Moghadasian MH. Bioavailability of hydroxycinnamates: a brief review of in vivo and in vitro studies. Phytochem Rev. 2010;9(1):133–45.CrossRef
33.
Psotova J, Lasovsky J, Vicar J. Metal chelating properties, electrochemical behavior, Scavenging and cytoprotective activities of six natural phenolics. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2003;147:147–53.CrossRefPubMed
34.
Hudson EA, Dinh PA, Kokubun T, Simmonds MS, Gescher A. Characterization of potentially chemopreventive phenols in extracts of brown rice that inhibit the growth of human breast and colon cancer cells. Cancer Epidemiol Biomarkers Prev. 2000;9:1163–70.PubMed
35.
Park EH, Kahng JH. Suppressive effects propolis in rate adjuvant arthritis. Arch Pharm Res. 1995;22:554–8.CrossRef
36.
Rajendra-Prasad N, Karthikeyan A, Karthikeyan S, Reddy BV. Inhibitory effect of caffeic acid on cancer cell proliferation by oxidative mechanism in human HT-1080 fibrosarcoma cell line. Mol Cell Biochem. 2011;349:11–9.CrossRefPubMed
37.
Fesen MR, Pommier Y, Leteurtre E, Hiroguchi S, Yung J, Kohn KW. Inhibition of HIV-1 integrase by flavones, caffeic acid phenyl ester (CAPE), related compound. Biochem Pharmacol. 1994;48:595–608.CrossRefPubMed
38.
Frank H, Thiel D, Macleod J. Mass spectroscopic detection of cross-linked fatty acids formed during radical induced lesion of lipid membranes. Biochem J. 1989;260:873–5.PubMedCentralPubMed
39.
Ikeda K, Tsujimoto K, Uozaki M, Nishide M, Suzuki Y, Koyama AH, et al. Inhibition of multiplication of herpes simplex virus by caffeic acid. Int J Mol Med. 2011;28(4):595–8.PubMed
40.
Morton LW, Croft KD, Puddey IB, Byrne L. Phenolic acids protect low density lipoproteins from peroxynitrite-mediated modification in vitro. Redox Rep. 2000;5:124–5.CrossRefPubMed
41.
Tsuji M, Takeda H, Matsumiya T. Identification of a novel anti-depressive substance extracted from Perillae Herba. Jpn J Pharmacol. 2001;85:256P.
42.
Takeda H, Tsuji M, Yamada T, Masuya J, Matsushita K, Tahara M, et al. Caffeic acid attenuates the decrease in cortical BDNF mRNA expression induced by exposure to forced swimming stress in mice. Eur J Pharmacol. 2006;534(1–3):115–21.CrossRefPubMed
43.
Joyeux M, Lobstein A, Anton R, Mortier F. Comparative antilipoperoxidant, antinecrotic and scavenging properties of terpenes and biflawones from ginkgo and some flavonoids. Planta Med. 1995;61:126–9.CrossRefPubMed
44.
Chao CY, Mong MC, Chan KC, Yin MC. Anti-glycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice. Mol Nutr Food Res. 2010;54:388–95.CrossRefPubMed
45.
Chao PC, Hsu CC, Yin MC. Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice. Nutr Metab (Lond). 2009;6:33.CrossRef
46.
Jung UJ, Lee MK, Park YB, Jeon SM, Choi MS. Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice. J Pharmacol Exp Ther. 2006;318(2):476–83.CrossRefPubMed
47.
Cheng JT, Liu IM, Tzeng TF, Chen WC, Hayakawa S, Yamamoto T. Release of beta-endorphin by caffeic acid to lower plasma glucose in streptozotocin-induced diabetic rats. Horm Metab Res. 2003;35(4):251–8.CrossRefPubMed
48.
Yang JQ, Zhou QX, Liu BZ BZ, He BC. Protection of mouse brain from aluminum-induced damage by caffeic acid. CNS Neurosci Ther. 2008;14:10–6.CrossRefPubMed
49.
Zhang L, Zhang WP, Chen KD, Qian XD, Fang SH, Wei EQ. Caffeic acid attenuates neuronal damage astrogliosis and glial scar formation in mouse brain with cryoinjury. Life Sci. 2007;80(6):530–7.CrossRefPubMed
50.
Altuğ ME, Serarslan Y, Bal R, Kontaş T, Ekici F, Melek IM, et al. Caffeic acid phenethyl ester protects rabbit brains against permanent focal ischemia by antioxidant action: a biochemical and planimetric study. Brain Res. 2008;1201:135–42.CrossRefPubMed
51.
Li Z, Choi DY, Shin EJ, Hunter RL, Jin CH, Wie MB, et al. Phenidone protects the nigral dopaminergic neurons from LPS-induced neurotoxicity. Neurosci Lett. 2008;445:1–6.CrossRefPubMed
52.
Wang H, Jiang R, He Q, Zhang Y, Zhang Y, Li Y, et al. Expression pattern of peroxisome proliferator-activated receptors in rat hippocampus following cerebral ischemia and reperfusion injury. PPAR Res. 2012;2012:1155–64.
53.
54.
Pan YQ, Zhang P, Yang JQ, Su Q. 5-lipoxygenase expression in a brain damage model induced by chronic oral administration of aluminum. Neural Regen Res. 2010;5:1634–8.
55.
Zhang J, Yang JQ, He BC, Zhou QX, Yu HR, Tang Y, et al. Berberine and total base from rhizoma coptis chinensis attenuate brain injury in an aluminum- induced rat model of neurodegenerative disease. Saudi Med J. 2009;30:760–6.PubMed
56.
Zhou Y, Wei EQ, Fang SH, Chu LS, Wang ML, Zhang WP, et al. Spatio-temporal properties of 5-lipoxygenase expression and activation in the brain after focal cerebral ischemia in rats. Life Sci. 2006;79:1645–56.CrossRefPubMed
57.
Chu LS, Fang SH, Zhou Y, Yin YJ, Chen WY, Li JH, et al. Minocycline inhibits 5-lipoxygenase expression and accelerates functional recovery in chronic phase of focal cerebral ischemia in rats. Life Sci. 2010;86:170–7.CrossRefPubMed
58.
Irmak MK, Fadillioglu E, Sogut S, Erdoqan H, Gulec M, Ozer M, et al. Effects of caffeic acid phenethyl ester and alpha-tocopherol on reperfusion injury in rat brain. Cell Biochem Funct. 2003;21:283–9.CrossRefPubMed
59.
Cao W, Carney JM, Duchon A, Floyd RA, Chevion M. Oxygen free radicals involvement in ischemia and reperfusion injury to brain. Neurosci Lett. 1998;88:233–8.CrossRef
60.
Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab. 2001;21:2–14.CrossRefPubMed
61.
Choi-Kwon S, Park KA, Lee HJ, Park MS, Lee JH, Jeon SE, et al. Temporal changes in cerebral antioxidant enzyme activities after ischemia and reperfusion in a rat focal brain ischemia model: effect of dietary fish oil. Brain Res Dev Brain Res. 2004;152:11–8.CrossRefPubMed
62.
Duncan J. An adaptive coding model of neural function in prefrontal cortex. Nat Rev Neurosci. 2001;2:820–9.CrossRefPubMed
63.
Yasuoka N, Nakajima W, Ishida A, Takada G. Neuroprotection of edaravone on hypoxic–ischemic brain injury in neonatal rats. Brain Res Dev Brain Res. 2004;151(1–2):129–39.CrossRefPubMed
64.
Yoshida H, Yanai H, Namiki Y, Fukatsu-Sasaki K, Furutani N, Tada N. Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. CNS Drug Rev. 2006;12(1):9–20.CrossRefPubMed
65.
Castelluccio C, Paganga G, Melikian N, Bolwell GP, Pridham J, Sampson J, et al. Antioxidant potential of intermediates in phenylpropanoid metabolism in higher plants. FEBS Lett. 1995;368(1):188–92.CrossRefPubMed
66.
Kono Y, Kobayashi K, Tagawa S, Adachi K, Ueda A, Sawa Y, et al. Antioxidant activity of polyphenolics in diets. Rate constants of reactions of chlorogenic acid and caffeic acid with reactive species of oxygen and nitrogen. Biochim Biophys Acta. 1997;1335(3):335–42.CrossRefPubMed
67.
Coffey MJ, Serezani CH, Phare SM, Flamand N, Peters-Golden M. NADPH oxidase deficiency results in reduced alveolar macrophage 5-lipoxygenase expression and decreased leukotriene synthesis. J Leukoc Biol. 2007;82(6):1585–91.CrossRefPubMed
Metadata
Title
The protective effect of caffeic acid on global cerebral ischemia-reperfusion injury in rats
Authors
Guojuan Liang
Bin Shi
Weinan Luo
Junqing Yang
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Behavioral and Brain Functions / Issue 1/2015
Electronic ISSN: 1744-9081
DOI
https://doi.org/10.1186/s12993-015-0064-x

Other articles of this Issue 1/2015

Behavioral and Brain Functions 1/2015 Go to the issue

Short paper

The roles of interoceptive sensitivity and metacognitive interoception in panic

Research

Electroacupuncture alleviates retrieval of pain memory and its effect on phosphorylation of cAMP response element-binding protein in anterior cingulate cortex in rats

Research

Development of behavioral parameters and ERPs in a novel-target visual detection paradigm in children, adolescents and young adults

Research

DRD2 and DRD4 genes related to cognitive deficits in HIV-infected adults who abuse alcohol

Research

Tat-induced histopathological alterations mediate hippocampus-associated behavioural impairments in rats

Research

Feasibility of focal cerebral ischemia and reperfusion surgery combined with chronic unpredictable mild stress to simulate the post-stroke depressive state in rats